Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-08 · accession 0001209191-23-017882 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-10 | 2023-03-08 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +240.6K | 888.2K | +37% | $0 |
| D | 2023-03-10 | 2023-03-08 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +120.3K | 120.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-08 | A | A | 240,595 | $0.00 | 888,193 | D | — | — | |
| 2 | Derivative | Performance-based Restricted Stock Units | 2023-03-08 | A | A | 120,297 | $0.00 | 120,297 | D | — · — to 2026-02-28 | 120,297 Class A Common Stock | (F2) Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share. |